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Objectives: To develop a short questionnaire measuring health-related quality of 
life (HRQoL) in patients with chronic wounds. MethOds: Three validated instru-
ments assessing HRQoL in chronic wounds, the Freiburg Life Quality Assessment 
for wounds (FLQA-w), the Cardiff Wound Impact Schedule (CWIS), and the Würzburg 
Wound Score (WWS), were filled in by 154 leg ulcer patients in a prospective 
study under routine care. For implementation in the new, shorter questionnaire 
Wound-QoL, those of all 92 items were selected that covered the core content of 
the three questionnaires and showed good psychometric properties (e. g. num-
ber of missing values, inter-item correlations). Internal consistency, convergent 
validity regarding four generic HRQoL measures such as the EQ-5D, and respon-
siveness of the Wound-QoL were analysed using the longitudinal study data on 
the selected items (so-called virtual validation). Subscales were determined with 
factor analysis. Item, instruction, and response scale wording of the Wound-QoL 
were harmonized. Results: Seventeen items were included in the Wound-QoL 
questionnaire which could be attributed to three subscales on everyday life, body, 
and psyche. Both global score and subscale scores were internally consistent with 
Cronbach’s alpha values between 0.71 and 0.91. The global score showed significant 
convergent validity (r= 0.48 to 0.69, depending on the criterion) and responsive-
ness regarding change in generic HRQoL (r= 0.18 to 0.52); the same was true for 
the subscale scores. cOnclusiOns: The Wound-QoL for measurement of HRQoL 
in chronic wounds proved to be internally consistent, valid, and responsive in the 
virtual validation analysis.
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Objectives: To develop an algorithm for mapping of disease-specific health related 
quality of life scores to the EQ-5D utility index for patients with PD. MethOds: 
EQ-5D and Parkinson’s disease Questionnaire (PDQ) data were obtained for 117 
UK PD patients (HY stages 1-4) via a cross-sectional survey of practicing clinicians 
and their patients. The EQ-5D utility index (UK Tariff) was regressed on PDQ-39/
PDQ-8 summary indices (SI) and PDQ-39 domains/PDQ-8 questions using OLS 
regression. Analysis on PDQ-39 domains/PDQ-8 questions was repeated using 
OLS with backward elimination. Two-part models (TPM) were conducted on PDQ-
39/8 SI and domains/questions respectively consisting of a logistic regression on 
whether EQ-5D< 1 followed by either OLS, GLM with gamma distribution and log 
link or identity link functions and GLM with Gaussian distribution with log link 
for the remainder. Mapping equations were used to predict utilities which were 
subsequently compared to those observed. Models were compared using RMSE 
values. Results: Compared to simple OLS [RMSE 0.1685-0.1924], a model with back-
ward elimination of variables did not improve predictive power. Out of the TPMs the 
best fitting models were GLM with gamma distribution and identity link function 
[RMSE 0.1666-0.1929] and GLM with Gaussian distribution and log link function 
[RMSE 0.1683-0.1912]. All models produced better results utilising the domains of 
PDQ-39 or individual questions of PDQ-8 than with the SI. cOnclusiOns: All map-
ping algorithms estimated utilities for patients with HY stage 1-4 with reasonable 
accuracy. Therefore, mapping functions reported could be used for predicting EQ-5D 
scores from either PDQ-39 or PDQ-8 when EQ-5D data were not collected. However, 
simple OLS, TPMs with gamma family and identity function and Gaussian family 
and log functions resulted in the best prediction and the smallest RMSE values. 
Further validation is needed to ascertain whether these mapping functions perform 
well for more advanced patients in HY stage 5.
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Objectives: Patients with Systemic Lupus Erythematosus (SLE) experience unmet 
medical needs and many inflammatory symptoms resulting in humanistic and 
economic burden. This study aimed to create a conceptual model of patient and eco-
nomic burden, and review patient-reported outcomes (PROs) used to measure such 
concepts in SLE clinical trials. MethOds: An SLE conceptual model was developed 
from structured review of published articles from 2007-June 2012 identified from 
literature databases (MEDLINE, PsycINFO, EconLit) plus other sources (PROLabels, 
FDA/EMA websites, Clinicaltrials.gov). PROs targeting key symptom/impact were 
identified from the literature. In the context of FDA guidance, the PROs were subject 
to in-depth review and assessed for face and content validity, and psychomet-
ric properties to determine appropriateness for use in SLE trials. Results: Pain, 
fatigue, cognition, daily activities, emotional well-being, physical/social functioning, 
and work productivity were in the conceptual model identified as key SLE concepts. 
Of the 63 articles reviewed, 31 reported PRO data. From these and the other sources, 
14 PROs were selected for review including SLE-specific health-related quality of life 
(HRQoL) measures (n= 3), work productivity (n= 1), and generic measures of fatigue 
(n= 3), pain (n= 2), depression (n= 2) and HRQoL (n= 3) as these were deemed salient 
for patients with SLE in the literature. The FACIT-Fatigue, BPI-SF (pain) and LupusQoL 
demonstrated the strongest face validity, conceptual coverage and psychometric 
properties measuring key concepts in the conceptual model. All PROs reviewed, 
symptoms (joint pain, shortness of breath), and generic physical (PCS) and men-
tal (MCS) summary measures (SF-36). The resulting 10X10 correlation matrix (3 
disease-specific, 2 generic) for each disease was evaluated to test convergent 
validity (correlations > 0.40 between different methods of measuring the same 
disease) and discriminant validity (significantly lower correlations between dif-
ferent diseases measured by the same method). The MTMM matrix was also ana-
lyzed using principal component analysis (PCA) to test for disease versus methods 
factors. Results: The MTMM matrix yielded strong evidence that patients dis-
criminated the impact of one condition from the other. In support of convergent 
validity, disease specific QOL impact, severity and symptom measures (joint pain 
for OA, SOB for respiratory) correlated substantially for asthma (0.516 - 0.765) 
and OA (0.465 - 0.774). In support of discriminant validity, different diseases 
measured by the same method correlated significantly lower (0.264 - 0.286). 
PCA yielded two disease-specific factors (OA and respiratory) with high loadings 
across methods for OA (0.748 - 0.871 and respiratory (0.687 - 0.890) and low sec-
ondary loadings (0.085 - 0.262). Generic PCS and MCS measures correlated lower 
than disease-specific measures, as hypothesized. 2-method (QOL impact, sever-
ity) MTMM validations replicated these results across 37 pairs of over-sampled 
comorbid conditions. cOnclusiOns: Results strongly support the convergent-
discriminant validity of survey measures of QOL impact based on attributions to 
OA and respiratory disease and suggest that disease-specific attributions may 
improve the validity of QOL impact attributions for other common pairs of comor-
bid conditions.
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Objectives: Mapping algorithms can translate disease-specific or generic 
health-related quality of life measurements into values obtained from prefer-
ence-based instruments such as the EuroQol 5-dimension questionnaire (EQ-
5D). The Oxford Hip Score (OHS) is a disease-specific instrument widely used by 
orthopaedic surgeons to assess outcomes from hip surgery. There is an algorithm 
for estimating mean EQ-5D scores from the OHS, but this was developed using 
early response mapping methods and has limited external validation. We have 
developed a new mapping algorithm to translate OHS results into EQ-5D domain 
responses and utilities in a large UK dataset using direct and response mapping 
methods. MethOds: OHS and EQ-5D responses were extracted from the publicly 
available National Patient Reported Outcomes Measures (PROMs) database. The 
sample of complete data pairs (n= 126 862) was split into estimating (n= 51 800, 
years 2009–10) and external validation (n= 75 062, years 2010–12) samples. EQ-5D 
utilities were estimated directly using ordinary least squares regression and two-
part models. EQ-5D responses were estimated using ordered and multinomial logit 
models. For the two-part and the multinomial logit models, the expected value 
method was used to calculate utilities. Performance was evaluated using mean 
square error (MSE) and mean absolute error (MAE). Results: The two-part models 
and the ordered or multinomial regressions performed better than ordinary least 
square regression. In external validation, the MSE (MAE) was 0.0319 (0.1286) for 
the two-part model and 0.0315 (0.1249) for response mapping. For EQ-5D index 
values > 0.5 (better health states), response mapping predictions had a slightly 
smaller MSE and MAE than direct method predictions. Both indirect and direct 
approaches predicted higher MSE and MAE when EQ-5D < 0.5. cOnclusiOns: 
Response mapping between OHS and EQ-5D was similar or slightly more predic-
tive than direct mapping. Further research is needed to improve the performance 
of these techniques in poorer health states.
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Objectives: A large number of quality of life (QoL) values for patients with coro-
nary heart disease (CHD) are available in the literature. From the abundance of QoL 
values in CHD, only preference-based values can be directly applied in cost-utility 
analysis (CUA). In this study we performed a multivariate meta-regression analysis 
of the preference-based QoL values in CHD. Our aim was to obtain a summarized 
QoL estimate while accounting for study-level covariates and for the correlation 
between multiple outcomes both within and between studies. MethOds: Studies 
were considered eligible for this analysis if they reported mean QoL values, standard 
deviations and the instrument for measuring QoL (e.g. EQ-5D, SF-6D). Additionally, 
studies reporting separate values of SF-36 and SF-12 QoL instruments were included. 
The scores of the SF-36 and SF-12 QoL were mapped onto EQ-5D and SF-6D values. 
Mapped preference-based values were added to the base-case data set that con-
sisted only of published preference-based QoL values. Finally, a multivariate meta-
regression model was used in order to estimate pooled, instrument-specific QoL 
in CHD. Results: Our systematic search identified 35 eligible studies reporting 43 
preference-based QoL values in CHD as well as 46 studies reporting QoL scores of 
SF-36 and SF-12. Following instrument-specific QoL estimates were obtained when 
conducting the analysis on the base-case data set: 0.77 (EQ-5D UK), 0.79 (EQ-5D 
US), 0.65 (SF-6D), 0.85 (15D), 0.44 (HUI3) and 0.63 (QWB). Age was the only study-
level covariate that showed an influence on instrument-specific QoL estimates. 
Significant heterogeneity was observed when the analysis was conducted on the 
expanded data set. cOnclusiOns: This study represents the first meta-analysis 
of QoL in CHD. Given the abundance of QoL values in CHD on the one hand and 
the requirement for single, accurate QoL values in CUA on the other hand, pooled 
estimates of QoL could be highly applicable in CUA.
